ONXX: at a 10% quarter to quarter sales increase, Nexavar sales will double in China in TWO years not three. That's all fine and dandy, but I used the average q/q growth. So I'm not really sure what part of my math you're correcting. I am not sure why you don't think the increase can hold up. Simple: Because the 10% q/q increase hasn't held up. Over the last year it was 6.5% q/q on average. I'll be happy to be wrong, but I'm simply going off as much of the data as are available rather than cherry picking one quarter's growth.